Patent US3959359A successfully refreshed from Google Patents.
US3959359A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Phenoxyalkylamines, process for their preparation and therapeutical composition containing same
Assignee: Laroche Navarron SA
•
Filing: 1974-12-11
•
Granted: 1976-05-25
•
Expires: 1994-12-11
Abstract
Abstract This invention relates to phenoxyalkylamines having the formula:
Inventors
- 👤 Henri Pinhas
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 16:45
CPC Classifications
C; C07; C07C; C07C217/00; C07C217/02; C07C217/04; C07C217/06; C07C217/14; C07C217/18
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
58 words
A compound selected from the group consisting of phenoxyalkylamines of the formula: ##SPC13## wherein R 2 is a radical selected from the group consisting of hydrogen and methyl and A is a radical selected from the group consisting of ##EQU7## wherein R 1 is an alkyl radical having 2-6 carbon atoms and the non-toxic acid addition salts thereof.
Claim 2
Dependent Claim
58 words
A compound selected from the group consisting of phenoxyalkylamines of the formula: ##SPC13## wherein R 2 is a radical selected from the group consisting of hydrogen and methyl and A is a radical selected from the group consisting of ##EQU7## wherein R 1 is an alkyl radical having 2-6 carbon atoms and the non-toxic acid addition salts thereof.
Claim 3
Dependent Claim
18 words
A compound as claimed in claim 1, wherein R 1 is an alkyl radical having 2-3 carbon atoms.
Claim 4
Dependent Claim
7 words
4-[2-(1-methyl-phenethylamino-ethoxy]-propiophenone and its non-toxic acid addition salts.
Claim 5
Dependent Claim
7 words
4-[2-(1-methyl-phenethylamino-ethoxy]-propiophenone and its non-toxic acid addition salts.
Claim 6
Dependent Claim
7 words
4-[2-(1-methyl-phenethylamino)-propoxy]-propiophenone and its non-toxic acid addition salts.
Claim 7
Dependent Claim
7 words
4-[2-(1-methyl-phenethylamino)-propoxy]-propiophenone and its non-toxic acid addition salts.
Claim 8
Dependent Claim
9 words
1(1-hydroxy propyl)-4-[2-(1-methyl phenethylamino)-ethoxy]-benzene and its non-toxic acid addition salts.
Claim 9
Dependent Claim
9 words
1(1-hydroxy propyl)-4-[2-(1-methyl phenethylamino)-ethoxy]-benzene and its non-toxic acid addition salts.
Claim 10
Dependent Claim
7 words
4-[2-(1-methyl-phenethylamino)-ethoxy]-butyrophenone and its non-toxic acid addition salts.
Claim 11
Dependent Claim
7 words
4-[2-(1-methyl-phenethylamino)-ethoxy]-butyrophenone and its non-toxic acid addition salts.
Claim 12
Independent Claim
77 words
A method for the treatment of coronary insufficiency which comprises administering to a patient a therapeutically effective quantity of a compound selected from the group consisting of phenoxyalkylamines of the formula: ##SPC14## wherein R 2 is a radical selected from the group consisting of hydrogen and methyl and A is a radical selected from the group consisting of ##EQU8## wherein R 1 is an alkyl radical having 2-6 carbon atoms and the non-toxic acid addition salts thereof.
Claim 13
Independent Claim
77 words
A method for the treatment of coronary insufficiency which comprises administering to a patient a therapeutically effective quantity of a compound selected from the group consisting of phenoxyalkylamines of the formula: ##SPC14## wherein R 2 is a radical selected from the group consisting of hydrogen and methyl and A is a radical selected from the group consisting of ##EQU8## wherein R 1 is an alkyl radical having 2-6 carbon atoms and the non-toxic acid addition salts thereof.
Claim 14
Dependent Claim
21 words
A method as claimed in claim 7, which comprises administering orally from 100 to 600 mg of compound per 24 hours.
Claim 15
Dependent Claim
27 words
A composition for the treatment of coronary insufficiency which comprises a therapeutically effective quantity of a compound as claimed in claim 1, and a pharmaceutically acceptable vehicle.
Claim 16
Dependent Claim
27 words
A composition for the treatment of coronary insufficiency which comprises a therapeutically effective quantity of a compound as claimed in claim 2, and a pharmaceutically acceptable vehicle.
Claim 17
Dependent Claim
27 words
A composition for the treatment of coronary insufficiency which comprises a therapeutically effective quantity of a compound as claimed in claim 5, and a pharmaceutically acceptable vehicle.
References Cited (Backward Citations)
US3278601A
Cited
US3337628A
Cited
US3501769A
Cited
US3437731A
Cited
US3410901A
Cited
US3513198A
Cited
US3726919A
Cited
US3843725A
Cited
US3873620A
Cited
US3892799A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1979-05-25 | 1979-11-24 | 1980-05-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1983-05-25 | 1983-11-24 | 1984-05-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1987-05-25 | 1987-11-24 | 1988-05-25 | $7700.00 | Window Closed / Lapsed |